Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen s Latest Acquisition Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Oct. 10 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Aug. 26.

 

1. Invitrogen to Acquire Molecular Labeling Firms Quantum Dot and BioPixels (from Oct. 6)

2. PerkinElmer, Divesting Three Units, Shifts Focus on Health Sciences, Photonics (from Oct. 7)

3. Wary of Bioinformatics Bust, Biopharma Spends its IT Dollars More Wisely (from Oct. 4)

4. ABI/MDS Sciex Sell 21 Mass Specs to CDC, State Health Labs (from Oct. 3)

5. PerkinElmer Stock Climbs 7.4 Percent on Divestiture Announcement (from Oct. 7)

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.